The Recall Desk
ModerateFDA (Drugs)·D-1621-2020·Announced 2020-09-30

Preferred Pharmaceuticals Recalls Nature-Throid Tablets Due to CGMP Deviations

Preferred Pharmaceuticals is voluntarily recalling Nature-Throid tablets due to Current Good Manufacturing Practice (CGMP) deviations. The affected repackaged tablets were sold to three physicians in California and Georgia.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that might cause temporary or medically reversible health consequences. The source text does not report any specific illnesses or injuries, and the hazard is related to manufacturing deviations rather than a high-risk pathogen or structural defect.

Plain-English summary

Preferred Pharmaceuticals, Inc. is voluntarily recalling Nature-Throid, 1/2 Grain, 32.5 mg tablets. The recall was initiated on September 2, 2020, and was classified as Class II by the FDA. The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations.

The affected product consists of 100-count tablets containing Thyroid U.S.P., Liothyronine (T3), and Levothyroxine (T4). The specific lots involved are L2717G (Exp. 12/31/2020), B2618A (Exp. 12/21/2020), and C1419P (Exp. 2/28/2021). The NDC number for the product is 68788-9283-01.

The repackaged tablets were sold to three physicians located in California and Georgia. The recall status is currently terminated as of April 25, 2024. Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates.

The recalled product

Product
Nature-Throid, 1/2 Grain, 32.5 mg (Thyroid U.S.P. 1/2 gr. (32.5 mg)/Liothyronine (T3) 4.5mcg/Levothyroxine (T4) 19mch, 100-count tablets, Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc. NDC 68788-9283-01

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (6)

  • Lot #: L2717G
  • Exp. Date: 12/31/2020
  • Lot #: B2618A
  • Exp. Date: 12/21/2020
  • Lot #: C1419P
  • Exp. Date: 2/28/2021

Distribution

Distributed in 2 states:

Part of a larger recall action

This product is one of 4 recalled by Preferred Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →

Same hazard · cgmp deviations

See all →